Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating PF-08032562 in people with advanced or metastatic solid tumors, including breast cancer and colorectal cancer. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Adenocarcinoma
• Colorectal Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• PF-08032562

Snippet

Sponsor: Pfizer | Conditions: Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-) | Phase 1 | Status: RECRUITING